Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverVVOS
HealthcareNCMUSD

Vivos Therapeutics, Inc.

$0.15+2.0%
52w low $0.13$3.42 52w high
Market data · updated 17h ago
Market data
Market cap
$5.46M
52w range
$0.13 - $3.42
Beta
6.12
Sector
Healthcare
Data quality
75/100
Valuation
fair value estimate
$0.31
Margin of safety
+103.9%
Quality & efficiency
Moat score
36/100
Return on equity
-1599.8%
Profit margin
-127.7%
Growth & analysts
Revenue growth
+70.5%
Analyst target
$2.12
Target upside
+1292.5%
Analysts
3
Run the 10-point checklist before you buy How these numbers are made

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Valuation

ValueGrowthProfitHealthIncome62QUALITY
Overall Rating
24
Very low quality
Very low quality

Derived from filed metrics · High confidence (75% of the inputs available)

Moat Score36
Fair value estimate
$0.31+103.9% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$5.46M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+70.5%
Profit Margin
-127.7%
ROE
-1599.8%
Debt / Equity
0.00
Beta
6.12
High GrowthBeaten Down

Statistics

Similar Stocks · Healthcare

Latest News · VVOS